Equities

Novartis AG

0QM7:LSE

Novartis AG

  • Price (CHF)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes.
More ▼

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
0QM7:LSE since
announced
Transaction
value
Avidity Biosciences IncAnnounced26 Oct 202526 Oct 2025Announced--9.99bn
Tourmaline Bio IncDeal completed09 Sep 202509 Sep 2025Deal completed--1.37bn
Regulus Therapeutics IncDeal completed30 Apr 202530 Apr 2025Deal completed--1.62bn
Anthos Therapeutics IncDeal completed11 Feb 202511 Feb 2025Deal completed--3.08bn
Data delayed at least 20 minutes.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.